267 related articles for article (PubMed ID: 19043557)
1. A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics.
Ganesh VK; Rivera JJ; Smeds E; Ko YP; Bowden MG; Wann ER; Gurusiddappa S; Fitzgerald JR; Höök M
PLoS Pathog; 2008 Nov; 4(11):e1000226. PubMed ID: 19043557
[TBL] [Abstract][Full Text] [Related]
2. Identification of residues in the Staphylococcus aureus fibrinogen-binding MSCRAMM clumping factor A (ClfA) that are important for ligand binding.
Hartford OM; Wann ER; Höök M; Foster TJ
J Biol Chem; 2001 Jan; 276(4):2466-73. PubMed ID: 11044451
[TBL] [Abstract][Full Text] [Related]
3.
Herman-Bausier P; Labate C; Towell AM; Derclaye S; Geoghegan JA; Dufrêne YF
Proc Natl Acad Sci U S A; 2018 May; 115(21):5564-5569. PubMed ID: 29735708
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of the interaction of staphylococcal microbial surface components recognizing adhesive matrix molecules (MSCRAMM) ClfA and Fbl with fibrinogen.
Geoghegan JA; Ganesh VK; Smeds E; Liang X; Höök M; Foster TJ
J Biol Chem; 2010 Feb; 285(9):6208-16. PubMed ID: 20007717
[TBL] [Abstract][Full Text] [Related]
5. Lessons from the Crystal Structure of the S. aureus Surface Protein Clumping Factor A in Complex With Tefibazumab, an Inhibiting Monoclonal Antibody.
Ganesh VK; Liang X; Geoghegan JA; Cohen ALV; Venugopalan N; Foster TJ; Hook M
EBioMedicine; 2016 Nov; 13():328-338. PubMed ID: 27789272
[TBL] [Abstract][Full Text] [Related]
6. The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen.
Wann ER; Gurusiddappa S; Hook M
J Biol Chem; 2000 May; 275(18):13863-71. PubMed ID: 10788510
[TBL] [Abstract][Full Text] [Related]
7. A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure.
Hawkins J; Kodali S; Matsuka YV; McNeil LK; Mininni T; Scully IL; Vernachio JH; Severina E; Girgenti D; Jansen KU; Anderson AS; Donald RG
Clin Vaccine Immunol; 2012 Oct; 19(10):1641-50. PubMed ID: 22896688
[TBL] [Abstract][Full Text] [Related]
8. Mechanostability of the Fibrinogen Bridge between Staphylococcal Surface Protein ClfA and Endothelial Cell Integrin α
Viela F; Speziale P; Pietrocola G; Dufrêne YF
Nano Lett; 2019 Oct; 19(10):7400-7410. PubMed ID: 31532212
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the Dual Role of Clumping Factor A in S. Aureus Adhesion to Endothelium in Absence and Presence of Plasma.
Claes J; Ditkowski B; Liesenborghs L; Veloso TR; Entenza JM; Moreillon P; Vanassche T; Verhamme P; Hoylaerts MF; Heying R
Thromb Haemost; 2018 Jul; 118(7):1230-1241. PubMed ID: 29909601
[TBL] [Abstract][Full Text] [Related]
10. Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus.
McDevitt D; Francois P; Vaudaux P; Foster TJ
Mol Microbiol; 1995 Jun; 16(5):895-907. PubMed ID: 7476187
[TBL] [Abstract][Full Text] [Related]
11. Structural and biochemical characterization of Staphylococcus aureus clumping factor B/ligand interactions.
Ganesh VK; Barbu EM; Deivanayagam CC; Le B; Anderson AS; Matsuka YV; Lin SL; Foster TJ; Narayana SV; Höök M
J Biol Chem; 2011 Jul; 286(29):25963-72. PubMed ID: 21543319
[TBL] [Abstract][Full Text] [Related]
12. Clumping factor A-mediated virulence during Staphylococcus aureus infection is retained despite fibrinogen depletion.
Palmqvist N; Josefsson E; Tarkowski A
Microbes Infect; 2004 Feb; 6(2):196-201. PubMed ID: 14998518
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen.
McDevitt D; Nanavaty T; House-Pompeo K; Bell E; Turner N; McIntire L; Foster T; Höök M
Eur J Biochem; 1997 Jul; 247(1):416-24. PubMed ID: 9249055
[TBL] [Abstract][Full Text] [Related]
14. The dipeptide repeat region of the fibrinogen-binding protein (clumping factor) is required for functional expression of the fibrinogen-binding domain on the Staphylococcus aureus cell surface.
Hartford O; Francois P; Vaudaux P; Foster TJ
Mol Microbiol; 1997 Sep; 25(6):1065-76. PubMed ID: 9350863
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.
Scully IL; Timofeyeva Y; Keeney D; Matsuka YV; Severina E; McNeil LK; Nanra J; Hu G; Liberator PA; Jansen KU; Anderson AS
Vaccine; 2015 Oct; 33(41):5452-5457. PubMed ID: 26319743
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the "dock, lock, and latch" ligand binding mechanism of the staphylococcal microbial surface component recognizing adhesive matrix molecules (MSCRAMM) SdrG.
Bowden MG; Heuck AP; Ponnuraj K; Kolosova E; Choe D; Gurusiddappa S; Narayana SVL; Johnson AE; Höök M
J Biol Chem; 2008 Jan; 283(1):638-647. PubMed ID: 17991749
[TBL] [Abstract][Full Text] [Related]
17. New potential role of serum apolipoprotein E mediated by its binding to clumping factor A during Staphylococcus aureus invasive infections to humans.
Elkhatib WF; Hair PS; Nyalwidhe JO; Cunnion KM
J Med Microbiol; 2015 Apr; 64(Pt 4):335-343. PubMed ID: 25878259
[TBL] [Abstract][Full Text] [Related]
18. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
Liu CZ; Shih MH; Tsai PJ
Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
[TBL] [Abstract][Full Text] [Related]
19. The Complex Fibrinogen Interactions of the
Thomas S; Liu W; Arora S; Ganesh V; Ko YP; Höök M
Front Cell Infect Microbiol; 2019; 9():106. PubMed ID: 31041195
[TBL] [Abstract][Full Text] [Related]
20. Coagulase and Efb of Staphylococcus aureus Have a Common Fibrinogen Binding Motif.
Ko YP; Kang M; Ganesh VK; Ravirajan D; Li B; Höök M
mBio; 2016 Jan; 7(1):e01885-15. PubMed ID: 26733070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
